Wealth Advisors of Tampa Bay’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-76,354
Closed -$5.54M 107
2021
Q4
$5.54M Buy
76,354
+38,843
+104% +$2.68M 1.36% 34
2021
Q3
$2.62M Sell
37,511
-19
-0.1% -$1.33K 1.45% 36
2021
Q2
$2.58M Buy
37,530
+7,387
+25% +$493K 1.44% 35
2021
Q1
$1.95M Buy
30,143
+12,296
+69% +$793K 1.15% 43
2020
Q4
$1.04M Sell
17,847
-13,660
-43% -$824K 0.73% 51
2020
Q3
$1.99M Buy
31,507
+4,417
+16% +$306K 1.48% 33
2020
Q2
$2.08M Buy
+27,090
New +$2.08M 1.74% 25

Other funds holding GILD

Wealth Advisors of Tampa Bay's GILD Position: Q1 2022 in Review

Wealth Advisors of Tampa Bay sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 76,354 shares — an estimated $5.54M sold.

Wealth Advisors of Tampa Bay first reported a position in GILD in Q2 2020 and held it in 7 quarters. The position peaked at $5.54M in Q4 2021. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Wealth Advisors of Tampa Bay reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Wealth Advisors of Tampa Bay sold 76,354 Gilead Sciences shares in Q1 2022, an estimated $5.54M.
  • Wealth Advisors of Tampa Bay first reported a position in Gilead Sciences in Q2 2020 and held it in 7 quarters.
  • Wealth Advisors of Tampa Bay's Gilead Sciences position peaked at $5.54M in Q4 2021.
  • 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Wealth Advisors of Tampa Bay's 13F filing for Q1 2022, filed 25 Apr 2022.